Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Net Income (2019 - 2025)

Historic Net Income for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to -$31433.0.

  • Volitionrx's Net Income rose 3319.09% to -$31433.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.3 million, marking a year-over-year increase of 3381.91%. This contributed to the annual value of -$27.0 million for FY2024, which is 2473.74% up from last year.
  • Per Volitionrx's latest filing, its Net Income stood at -$31433.0 for Q3 2025, which was up 3319.09% from $29992.0 recorded in Q2 2025.
  • Volitionrx's 5-year Net Income high stood at $94092.0 for Q4 2022, and its period low was -$9.5 million during Q2 2023.
  • Moreover, its 5-year median value for Net Income was $9424.0 (2021), whereas its average is -$2.9 million.
  • Its Net Income has fluctuated over the past 5 years, first surged by 79109.72% in 2022, then tumbled by 1258513.82% in 2023.
  • Quarter analysis of 5 years shows Volitionrx's Net Income stood at $73088.0 in 2021, then increased by 28.74% to $94092.0 in 2022, then tumbled by 9380.53% to -$8.7 million in 2023, then soared by 33.8% to -$5.8 million in 2024, then surged by 99.46% to -$31433.0 in 2025.
  • Its Net Income stands at -$31433.0 for Q3 2025, versus $29992.0 for Q2 2025 and -$5.5 million for Q1 2025.